HIV-AIDS | Microbicide Trials Network

Nebraska campaign targets HIV awareness with testing and education - KNOP

Thu, 09/12/2024 - 15:21

Nebraska campaign targets HIV awareness with testing and education - KNOP

Thu, 09/12/2024 - 15:21

USCHA: A Note From Paul - POZ

Thu, 09/12/2024 - 14:47

Spotted: GAIA’s Joyce Jere with former Warrior Festus Ezeli - InMenlo

Thu, 09/12/2024 - 14:45

Palm Springs AIDS Memorial Task Force Shares New Memorial Design - Palm Springs Tribune

Thu, 09/12/2024 - 14:19

Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? - U.S. News & World Report

Thu, 09/12/2024 - 13:49

Twice-yearly injection reduced HIV infections by 96 percent, company says - The Hill

Thu, 09/12/2024 - 13:21

Gilead Stock Rises on Positive Study Results for Twice-Yearly HIV Drug - The Wall Street Journal

Thu, 09/12/2024 - 13:13

Triple antibody therapy shows promise for long-lasting HIV control - Medical Xpress

Thu, 09/12/2024 - 13:12

National HIV/AIDS Strategy Quality of Life Goals Unlikely to Be Met - AJMC.com Managed Markets Network

Thu, 09/12/2024 - 13:03

PUBLIC HEALTH CORNER: National HIV/AIDs & Aging Awareness Day - Kirksville Daily Express and Daily News

Thu, 09/12/2024 - 13:00

Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? - HealthDay

Thu, 09/12/2024 - 12:45

Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? - Wyoming Tribune

Thu, 09/12/2024 - 12:45

Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? - NonStop Local Billings

Thu, 09/12/2024 - 12:45

Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? - The Mountaineer

Thu, 09/12/2024 - 12:45

The Critical Role of Transportation in HIV Prevention and Treatment - JPHMP Direct

Thu, 09/12/2024 - 11:40

Amida Care’s HIV and LGBTQ Clients and Staff Want You to Vote! [VIDEOS] - POZ

Thu, 09/12/2024 - 10:32

Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 Trial - BioSpace

Thu, 09/12/2024 - 10:18

Politics Causing Problem for Gen Z’s HIV Education – 2024 State of HIV Stigma Report - GLAAD

Thu, 09/12/2024 - 09:58

Methodology – 2024 State of HIV Stigma Report - GLAAD

Thu, 09/12/2024 - 09:56

Triple Antibody Therapy Shows Promise for Long-Las | Newswise - Newswise

Thu, 09/12/2024 - 09:05

HIV patients who lose short-term financial incentives to receive care don’t fare worse after payments cease - UC Berkeley School of Public Health

Thu, 09/12/2024 - 09:00

Twice-a-year injection reduced risk of HIV infection by 96%, drug company says — more than daily PrEP pill - CNN

Thu, 09/12/2024 - 08:48

Gilead’s twice-yearly antiviral protects against HIV infection in second large trial - STAT

Thu, 09/12/2024 - 08:40

Gilead's (GILD) Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada - StreetInsider.com

Thu, 09/12/2024 - 08:31

Exclusive: Lil’ Kim Announced As Headliner Of 33rd Annual AIDS Walk Atlanta Concert - atlantadailyworld

Thu, 09/12/2024 - 08:30

Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 Trial - Business Wire

Thu, 09/12/2024 - 08:30

'Sorry, but we won't be treating you' - BBC.com

Thu, 09/12/2024 - 07:08

Shelby County, a hotspot for HIV, forfeited $3M in federal HIV funding - Tennessee Lookout

Thu, 09/12/2024 - 06:04

Joyce I. Dennison, civil rights and AIDS activist, dies - Baltimore Sun

Thu, 09/12/2024 - 05:01